About this episode

Dr. Centor discusses the comparative risk for severe gastrointestinal adverse events associated with dulaglutide, semaglutide, and tirzepatide with Dr. Wajd Alkabbani.

More episodes of Annals On Call Podcast

• Physicians Not Providers · April 20, 2026 · 19 min
• Managing Inpatient Hyponatremia Part 2 · April 6, 2026 · 28 min
• Managing Outpatient Hyponatremia Part 1 · March 16, 2026 · 20 min
• Alzheimer Disease: A Diagnostic Challenge · March 2, 2026 · 22 min
• Hyponatremia Correction: How Fast Is Too Fast? · February 16, 2026 · 21 min
• The Role of Corticosteroids in Severe Pneumonia · February 2, 2026 · 20 min

Explore listener stats, chart rankings, contacts and more on the Annals On Call Podcast podcast page.